ABSTRACT. Leukotrienes may control fetal pulmonary vascular tone since infusions of putative leukotriene receptor antagonists markedly increase pulmonary blood flow and decrease pulmonary vascular resistance in fetal lambs. 'This hypothesis would be strengthened if inhibition of leukotriene synthesis also produced similar hemodynamic changes. We therefore studied the effects of piriprost (U 60257), a putative leukotriene synthesis inhibitor, on thirteen fetal lambs at 137 to 140 days gestation. In preliminary studies in four fetal lambs, doses of U 60257 greater than 20 mg/kg increased pulmonary blood flow. In the nine other fetal lambs, U 60257 (31.7 + 4.1 mg/kg) increased pulmonary blood flow by 502% ( p < 0.05) and decreased pulmonary vascular resistance by 87% ( p < 0.05). Pulmonary arterial and left atrial pressures were unchanged.
In the fetus, pulmonary blood flow is low, representing less than 10% of combined ventricular output. This low pulmonary blood flow is maintained by a high pulmonary vascular resistance (I). During the early part of gestation, the high pulmonary vascular resistance is likely maintained by the small cross-sectional area of the pulmonary vascular bed. During the latter part of gestation, the high pulmonary vascular resistance is likely maintained in part by active vasoconstriction of the muscularized small pulmonary arteries (1-3). The mechanisms involved in this vasoconstriction remain to be fully explored.
Leukotrienes C4 and D4, products of 5'-lipoxygenase pathway of arachidonic acid metabolism, induce pulmonary vasoconstriction in various species (4-8). They also may play a role in the development of hypoxic pulmonary hypertension (9-14). We have investigated'the role of leukotrienes in the control of high pulmonary vascular resistance and low pulmonary blood flow in fetal lambs. Infusions of putative leukotriene receptor antagonists (FPL 55712 and FPL 57231, Fisons, plc Loughborough, UK) increased pulmonary blood flow (3). This increase was similar in magnitude to the 8-to 10-fold increase in pulmonary blood flow occurring spontaneously with ventilation at birth (I). We concluded that leukotrienes may regulate pulmonary vascular resistance in the fetus. However, the hemodynamic effects produced by these leukotriene receptor antagonists may have been caused by nonspecific effects of these compounds. Our hypothesis that leukotrienes are involved in maintaining the pulmonary vascular resistance in the fetus would be strengthened if inhibition of leukotriene synthesis also produced similar hemodynamic changes. Therefore, we studied whether piriprost (U 60257, Upjohn Co., Kalamazoo, MI), a putative leukotriene synthesis inhibitor, produces a similar increase in pulmonary blood flow and decrease in pulmonary vascular resistance in fetal lambs. We also studied whether these changes are associated with alterations in the distribution of combined ventricular output.
METHODS
Thirteen pregnant ewes were operated on at 133 to 136 days of gestation under epidural anesthesia with 2% pontocaine hydrochloride and intermittent sedation with ketamine hydrochloride ( 1 to 2 mg/kg intravenous every 15-30 min). Polyvinyl catheters were placed in a maternal hind limb artery and vein. The uterus was exposed through a midline abdominal incision. Through a small uterine incision. a fetal hind limb was exteriorized. Fetal surgery was performed under local anesthesia with 0.5% lidocaine hydrochloride. We inserted polyvinyl catheters into the descending aorta through the pedal artery and into the inferior vena cava through the pedal vein. To prevent fetal movement, succinylcholine chloride was administered intravenously.
After closure of the first uterine incision, a second uterine incision was made to expose the fetal chest. A left lateral thoracotomy was performed in the third or fourth intercostal space. Polyvinyl catheters were inserted into the internal thoracic artery and vein and advanced to the ascending aorta and superior vena cava, respectively. The pericardium was then opened along the pulmonary trunk. Teflon cannulae connected to polyvinyl catheters were inserted into the left atrium, the pulmonary trunk (proximal to the main pulmonary artery-ductus arteriosus bifurcation), and the main pulmonary artery. A large bore polyvinyl catheter was inserted into the amniotic cavity. The chest and uterine incisions were closed. Amniotic fluid losses were replaced with warn1 0.9% saline. All the cathetcrs were brought to a pouch sewn to the ewe's flank, filled with heparin, and plugged. The maternal abdomen was closed in layers. On the day of surgery and cach day thcrcalier-. the e\\c rcccivcd one million 1J of' I'cnicillin ( i and 400 rng ol' Kanamycin sulfate i n t r a \ c n o u s l~. Antibiotics wcr-c also placed into the amniotic cavit!. 1 \vo to 4 days were allowed f i~r I-ccovcsk.
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T~m e a f t e r Injection ( m~n i from control. Pulmonary blood flow returned to control levels 120 min after the injection. U 60257 decreased pulmonary vascular resistance by 84% from 0.69 + 0.41 to 0.11 + 0.07 m m Hg. ml-' . m i n . I00 g lung tissue 30 min after the injection ( p < 0.05). The minimum pulmonary vascular resistance was 0.09 rt 0.07 m m Hg. ml-'. min. 100 g lung tissue, which represented a 87% decrease from control (Fig. 2) . Pulmonary vascular resistance returned to control levels 120 min after the injection. Pulmonary arterial and left atrial pressures were unchanged (Table I) . Descending aortic pressure was slightly increased 15 and 60 min after the injection ( p < 0.05). Heart rate decreased to less than 100 beats/min during and immediately after U 60257 injection. This bradycardia lasted for 15 rnin after the injection ( p < 0.05) ( Table 1 ). There were no other consistent changes in vascular pressures for the first 15 min after the injection. These hemodynamic changes occurred despite the development of hypoxemia 15 min after the injection ( p < 0.05) and acidosis 15 and 30 min after the injection ( p < 0.05) ( Table   1) .
Combined ventricular output was unchanged by the injection of U 60257. Myocardial blood flow was increased ( p < 0.05) while brain and upper body carcass flows were decreased ( p < 0.05). Placental blood flow represented a lower percentage of combined ventricular output ( p < 0.05) ( Table 2) .
DISCUSSION
The present study was performed to further investigate the role of leukotrienes in the control of pulmonary blood flow and pulmonary vascular resistance in fetal lambs. This study has shown that an intrapulmonary injection of piriprost (U 60257), a putative leukotriene synthesis inhibitor, significantly increases pulmonary blood flow and decreases pulmonary vascular resistance in late gestation fetal lambs. These changes were similar in magnitude to those that occur with the initiation of ventilation at birth (1). These changes were also similar in magnitude to those produced in late gestation fetal lambs by an intrapulmonary infusion of the leukotriene receptor antagonist FPL 5723 I, which increased pulmonary blood flow by 580% and decreased pulmonary vascular resistance by 87% (3). That structurally dissimilar compounds, one a putative leukotriene synthesis inhibitor and the other a putative leukotriene receptor antagonist, similarly increase pulmonary blood flow and decrease pulmonary vascular resistance, supports the hypothesis that leukotrienes play a role in controlling pulmonary vascular tone in the fetal lamb.
Several different mechanisms could be responsible for the observed increase in pulmonary blood flow. Constriction of the ductus arteriosus by U 60257 could produce an increase in pulmonary blood flow. However, this would be accompanied by an increase in pulmonary arterial pressure and in the pressure difference across the ductus arteriosus (19) . This did not occur in these studies and descending aortic pressure increased, indicating little or no effect on or of the ductus arteriosus. An overall increase in combined ventricular output might also be accompanied by an increase in pulmonary blood flow. This did not occur in these studies. There was a redistribution of combined ventricular output to maintain specific organ blood flow. The percentage of combined ventricular output going to the carcass, kidney, and placenta decreased. These changes are similar to those seen during ventilation in the fetus after pulmonary blood flow increases (2 1). Myocardial blood flow increased since pulmonary venous return and left ventricular output increased. Brain blood flow also decreased, although the mechanism producing this change is unclear.
The decreases in arterial blood PO2 and pH occurring after the intrapulmonary injection of U 60257 are likely caused by the decrease in the proportion of combined ventricular output distributed to the placenta. Acidosis and hypoxemia have previously been shown to reduce pulmonary blood flow and, therefore, played no role and even may have opposed the changes we observed (20) . It is more likely, therefore, that U 60257 had a more direct local effect on the pulmonary vasculature by inhibiting the production of leukotrienes which are known to be pulmonary vasoconstrictors. Although U 60257 and FPL 57231 had similar effects on pulmonary blood flow and vascular resistance in late gestation fetal lambs, they had different effects on some of the other variables. Both compounds similarly decreased arterial pH. U 60257 decreased heart rate and increased descending aortic pressure, while FPL 57231 increased heart rate and decreased pulmonary arterial and descending aortic pressures. U 60257 also decreased PaOz 15 min after the injection, while PaO, was not measured after 15 min of the infusion of FPL 57231. These differences may be due to differences in the mode of administration (bolus injection versus continuous infusion) or to direct effects of the compounds themselves.
U 60257 inhibits leukotriene synthesis by inhibiting both the 5'-lipoxygenase and LTD4 synthetase enzyme steps (22) (23) (24) (25) (26) . U 60257 has been shown to inhibit lcukotricnc production Ssom calcium ionophorc-challcrrgcd rat peritoneal m o n o n u c l c :~~ cclls and l'rorn human polyrnorl~lior~~~clcar leukocytes as \lie11 as fiom antigen-sensitid chopped human lung (22) (23) (24) (25) (26) . 11 00757 also prevents the pulmonary hqpcrtcnsion induced h> hypoxia in isolated pcrfused rat Ii~ngs ( I I ) and intact newborn lambs (14) anci prevents in a dose-dcpcncicnt manner the bronc1ioconst1-iction and pulmonary function ahnormalitics in anir-nal models of' asthma (27) (28) (29) . 'I'hc high doscs of'11 60257 used in our ctudq and others ;~rc necessary bccausc of' rapid plasma clearance of thc compound (22. 24. 27, 28) . 'l'tic plilsrna hall-life of'11 60257 is only 15 min (27) and may bc shorter in our preparation bccausc ol' the possibility ol' placental clearance. I .ongel-cfkcts of 11 00257 arc seen after aerosol administration (77).
11 00257 may also have other cfTccts on arachidonic acid mctabolisn~. At doscs 50 times greater than thosc nccdcd fi)r lcukotricnc synthesis inhibition. 11 60257 is a cornpet~tivc lnliibitor of the ;rctivity of'lcukotricnes on guinea pig ~lcurn (26) . 11 00257 docs not inhibit prostaglandin synthesis and actuallq increases thromboxanc syntlics~s from rat peritoneal mononilclear cclls (26) . I'hcrc arc other-interactions bctwccn the lipox)-gcnasc and cyclooxygenasc pathways. I.cukotriencs also stinlulatc prostaglandin and thromboxanc production. which. in turn. may mcdi;~tc some of the physiologic cfl'ccts (8. [30] [31] [32] .
Wc were unable to measure Icukotricnc concentrations in biologic fluids from thc lktal lambs and, thcrcfbrc. we cannot absolutely confir-m Icukott-icnc synthcsis inhibition by 11 00257 in thcsc studies. Ilowcvcr. the simil;lrity in pulmonar-! \ascular responses bctwccn 11 00257, which inhibits Icukotricnc s)nthcsis. and our previous studies with putative lcukotricnc receptor antagonists strongly suppol-t a I-olc fill-active l e~~k o t r i c n e production in maintenance of pulmonar? basoconstriction in thc f'ctus. Reversal o f the lcukotricnc clli'ct b) cithcr mechanism would then Icad to an increase in pulmonar) blood flow.
.l'lic results ol' our stud) show that piriprost (U 00257). : I putative inhibitor-of' Icukotricnc synthesis. incrcascs p~~l l i i o n a r y blood flow and decreases pulmonary vascular resistance in latc gestation fetal lambs. .Phc magnitude of'thcsc changes was similar to thosc caused by an intrapulmonar-y infusion o f F P I . 5723 I . a putative leukotrienc receptor antagonist ( 3 ) . and to thosc which occur with the onset of breathing at birth ( I ) . These results support thc hypothesis that Icukotricncs pla) a role in maintaining the high pulmonary vascular resistance in late gestation fetal lambs. 
